Clinical Trial: FDA Stays Silent on Trovan Charges

Lagos, Nigeria-FDA refused to confirm or deny that it was launching a criminal investigation into Pfizer’s conduct during a 1996 clinical trial for Trovan (alatrofloxacin) in Nigerian patients.

Related Content:

Pharmaceutical Executive-10-01-2001

National Crisis Supercedes Coverage Debate

PBMs: Merck-Medco in the Hot Seat

AIDS Treatments: Discounts Here to Stay